Cobro Ventures
ANGEL
INVESTOR TYPE
Active
STATUS
2
PROFESSIONALS
8
INVESTMENTS
5
PORTFOLIO
1
EXITS
Description
Cobro Ventures is an angel investment firm that encompasses a diversified portfolio of investments. The firm's portfolio companies range from new start-ups to enterprises that have become public and been acquired.
Website
Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel Group
Other Investor Types
Venture Capital
Primary Office
- 6455 Kedleston Ct
- McLean, VA 22101
- United States
Cobro Ventures Investments (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Frequency Therapeutics | 22-Jul-2019 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| 000000000 00000000 | 07-Jan-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| 000000000 00000000 | 05-Jan-2018 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000 00000 |
| 00 000000000000 | 29-Dec-2015 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000 00000 |
| 0000000 0000000 00 | 00000 (00000 | Leisure Facilities | Generating Revenue | 00000 00000 | ||
| 000000 | 00000 (00000 | Other Business Products and Services | Product In Beta Test | |||
| NeuroTennis | Early Stage VC | Accessories | Startup | |||
| Regenacy Pharmaceuticals | Angel (individual) | Pharmaceuticals | Clinical Trials - Phase 2 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cobro Ventures’s full profile, request a free trial.
Cobro Ventures Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 00000000 | 03-Oct-2019 | 000 | 0000 | Completed |
|
Cobro Ventures Team (2)
| Name | Title | Deals | Funds | Boards | Office | Contact Info |
|---|---|---|---|---|---|---|
| Alain Cohen | Co-Founder | 0 | 0 | McLean, VA | ||
| Marc Cohen | Co-Founder | 0 | 0 | McLean, VA |
Cobro Ventures Co-Investors (19)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| EG Capital Group | 1 | 0 | |
| Emigrant Capital | 0 | 0 | |
| Mizuho Securities | 0 | ||
| Novartis | 0 | 0 | |
| Roche Venture Fund | 0 | 0 |